![Autologous Mesenchymal Stem Cells Expressing Neurotrophic Factors Improved Function and Biomarkers in Progressive Multiple Sclerosis - Practical Neurology Autologous Mesenchymal Stem Cells Expressing Neurotrophic Factors Improved Function and Biomarkers in Progressive Multiple Sclerosis - Practical Neurology](https://core4.bmctoday.net/storage/images/Screen%20Shot%202021-10-25%20at%2011.31.55%20AM_1635176962.png)
Autologous Mesenchymal Stem Cells Expressing Neurotrophic Factors Improved Function and Biomarkers in Progressive Multiple Sclerosis - Practical Neurology
![Real maximum walking speed on short distance assessed by a corrected version of the Timed 25 Foot Walk Test (T25FW) R. Phan Ba 1, 2, P. Calay 1, 2, P. - ppt download Real maximum walking speed on short distance assessed by a corrected version of the Timed 25 Foot Walk Test (T25FW) R. Phan Ba 1, 2, P. Calay 1, 2, P. - ppt download](https://slideplayer.com/3471076/12/images/slide_1.jpg)
Real maximum walking speed on short distance assessed by a corrected version of the Timed 25 Foot Walk Test (T25FW) R. Phan Ba 1, 2, P. Calay 1, 2, P. - ppt download
![Comparison of the EDSS, Timed 25-Foot Walk, and the 9-Hole Peg Test as Clinical Trial Outcomes in Relapsing-Remitting Multiple Sclerosis | Neurology Comparison of the EDSS, Timed 25-Foot Walk, and the 9-Hole Peg Test as Clinical Trial Outcomes in Relapsing-Remitting Multiple Sclerosis | Neurology](https://n.neurology.org/content/neurology/97/16/e1560/F2.large.jpg)
Comparison of the EDSS, Timed 25-Foot Walk, and the 9-Hole Peg Test as Clinical Trial Outcomes in Relapsing-Remitting Multiple Sclerosis | Neurology
![Frontiers | The Dresden Protocol for Multidimensional Walking Assessment (DMWA) in Clinical Practice Frontiers | The Dresden Protocol for Multidimensional Walking Assessment (DMWA) in Clinical Practice](https://www.frontiersin.org/files/MyHome%20Article%20Library/582046/582046_Thumb_400.jpg)
Frontiers | The Dresden Protocol for Multidimensional Walking Assessment (DMWA) in Clinical Practice
![Functional intermuscular reduction in spasticity for people with multiple sclerosis - Bobbette J Miller, Thubi HA Kolobe, Rebecca D Larson, Brian A Pribble, Gabriel Pardo, Shirley A James, 2022 Functional intermuscular reduction in spasticity for people with multiple sclerosis - Bobbette J Miller, Thubi HA Kolobe, Rebecca D Larson, Brian A Pribble, Gabriel Pardo, Shirley A James, 2022](https://journals.sagepub.com/cms/10.1177/20552173211061547/asset/images/large/10.1177_20552173211061547-fig1.jpeg)
Functional intermuscular reduction in spasticity for people with multiple sclerosis - Bobbette J Miller, Thubi HA Kolobe, Rebecca D Larson, Brian A Pribble, Gabriel Pardo, Shirley A James, 2022
![PDF] The clinical meaning of walking speed as measured by the timed 25-foot walk in patients with multiple sclerosis. | Semantic Scholar PDF] The clinical meaning of walking speed as measured by the timed 25-foot walk in patients with multiple sclerosis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c049e10de8ca5bbe149beb669fd7a41e75c3d2b1/4-Table2-1.png)
PDF] The clinical meaning of walking speed as measured by the timed 25-foot walk in patients with multiple sclerosis. | Semantic Scholar
![On Biostatistics and Clinical Trials: Walk Distance versus Timed Walk - endpoints for measuring patients' function in clinical trials On Biostatistics and Clinical Trials: Walk Distance versus Timed Walk - endpoints for measuring patients' function in clinical trials](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjjiilcM2em7IcRZQn7K2AVuBINnDihfw9S3YvbZGw1I0_bUSultpS-XkF-P9p_GcWvGIdTY3ElSn6i4aI7vVWOyn7STWQ2NCByIKDa8LmXC9zcXaJ2vWmNyETO62Z7OYsbTBGeRwemHm7KYnYgi3JgNYSyFCbiZ0UDs2jZ6jzDZEoW1d3ucg/s467/Annotation%202023-11-02%20154205.jpg)
On Biostatistics and Clinical Trials: Walk Distance versus Timed Walk - endpoints for measuring patients' function in clinical trials
![Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis - Robert W Motl, Jeffrey A Cohen, Ralph Benedict, Glenn Phillips, Nicholas LaRocca, Lynn D Hudson, Richard Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis - Robert W Motl, Jeffrey A Cohen, Ralph Benedict, Glenn Phillips, Nicholas LaRocca, Lynn D Hudson, Richard](https://journals.sagepub.com/cms/10.1177/1352458517690823/asset/images/large/10.1177_1352458517690823-fig1.jpeg)
Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis - Robert W Motl, Jeffrey A Cohen, Ralph Benedict, Glenn Phillips, Nicholas LaRocca, Lynn D Hudson, Richard
![Walking disability measures in multiple sclerosis patients: Correlations with MRI-derived global and microstructural damage - ScienceDirect Walking disability measures in multiple sclerosis patients: Correlations with MRI-derived global and microstructural damage - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0022510X18303411-gr1.jpg)
Walking disability measures in multiple sclerosis patients: Correlations with MRI-derived global and microstructural damage - ScienceDirect
![Frontiers | The Dresden Protocol for Multidimensional Walking Assessment (DMWA) in Clinical Practice Frontiers | The Dresden Protocol for Multidimensional Walking Assessment (DMWA) in Clinical Practice](https://www.frontiersin.org/files/Articles/582046/fnins-14-582046-HTML/image_m/fnins-14-582046-t002.jpg)
Frontiers | The Dresden Protocol for Multidimensional Walking Assessment (DMWA) in Clinical Practice
![The timed 25-foot walk in a large cohort of multiple sclerosis patients - Anissa Kalinowski, Gary Cutter, Nina Bozinov, Jessica A Hinman, Michael Hittle, Robert Motl, Michelle Odden, Lorene M Nelson, 2022 The timed 25-foot walk in a large cohort of multiple sclerosis patients - Anissa Kalinowski, Gary Cutter, Nina Bozinov, Jessica A Hinman, Michael Hittle, Robert Motl, Michelle Odden, Lorene M Nelson, 2022](https://journals.sagepub.com/cms/10.1177/13524585211017013/asset/images/large/10.1177_13524585211017013-fig1.jpeg)
The timed 25-foot walk in a large cohort of multiple sclerosis patients - Anissa Kalinowski, Gary Cutter, Nina Bozinov, Jessica A Hinman, Michael Hittle, Robert Motl, Michelle Odden, Lorene M Nelson, 2022
![Measured times for the Timed 25-Foot Walk test following whole- body... | Download Scientific Diagram Measured times for the Timed 25-Foot Walk test following whole- body... | Download Scientific Diagram](https://www.researchgate.net/publication/338429317/figure/tbl2/AS:844706976112643@1578405245647/Measured-times-for-the-Timed-25-Foot-Walk-test-following-whole-body-cryotherapy.png)
Measured times for the Timed 25-Foot Walk test following whole- body... | Download Scientific Diagram
![PDF] A corrected version of the Timed-25 Foot Walk Test with a dynamic start to capture the maximum ambulation speed in multiple sclerosis patients. | Semantic Scholar PDF] A corrected version of the Timed-25 Foot Walk Test with a dynamic start to capture the maximum ambulation speed in multiple sclerosis patients. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/07dd8d40e3d7ffad1cbbddcecf9b7645271925a0/5-Figure3-1.png)
PDF] A corrected version of the Timed-25 Foot Walk Test with a dynamic start to capture the maximum ambulation speed in multiple sclerosis patients. | Semantic Scholar
![Sensors | Free Full-Text | Measuring Gait Stability in People with Multiple Sclerosis Using Different Sensor Locations and Time Scales Sensors | Free Full-Text | Measuring Gait Stability in People with Multiple Sclerosis Using Different Sensor Locations and Time Scales](https://pub.mdpi-res.com/sensors/sensors-21-04001/article_deploy/html/images/sensors-21-04001-g001.png?1623291704)